| Cash Flow | 2025-09-30 |
|---|---|
| Net profit/ (loss) | 32,081 |
| Other receivables | 31,000 |
| Account payables | -1,609 |
| Net cash used in operating activities | -528 |
| Series c shares | 40 |
| Net cash provided by financing activities | 40 |
| Net increase /(decrease) in cash | -488 |
| Cash and cash equivalents at beginning of period | 501 |
| Cash and cash equivalents at end of period | 13 |
CS DIAGNOSTICS CORP. (CSDX)
CS DIAGNOSTICS CORP. (CSDX)